NOx is biosynthesized in several cell types other than the vascular endothelium; therefore, it could be speculated that increased serum NOx in MetS, as seen in our results, could be due to eNOS inhibition and iNOS overexpression, as recently observed [21]. The gene discussed is NOS3; the disease is metabolic syndrome.